Intellia Therapeutics, Inc. · NASDAQ:NTLA
Dulac Edward J III sold 4,677 Intellia Therapeutics, Inc. shares (Form 4)
Traded Jul 2, 2026 · Filed Jul 6, 2026
On Jul 2, 2026, Dulac Edward J III (EVP, Chief Financial Officer) sold 4,677 Intellia Therapeutics, Inc. shares at US$18.00 for US$84,186 under a trading plan, leaving 156,286 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 4,677 shares
- Price
- US$18.00
- Value
- US$84,186
- Holding after
- 156,286 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | Sale | 4,677 | US$18.00 | 156,286 | Direct |
Source
Related
- Intellia Therapeutics, Inc.
- Dulac Edward J III
- Intellia Therapeutics, Inc. shareholders
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dube Michael P · Jul 6, 2026
- Form 4 · Verwiel Frank · Jun 10, 2026